I'm no expert, and I don't know all that much about stock choices, but this one just hit me over the head, after doing the technical research about the new product the medical communities are now investigating, Resveratrol(not a new product, but new testing is accelerating by some of the best in the industry!). Glaxo is also adding a new immunization line of products that competes with some of the others, and it is also a new-ish product related to diminishing the chances of developing cervical cancer.
New medical research is always interesting to me, so I'm basically just looking at that, and at what some of the larger investors have said about the company. I can give you a very short synopsis of what the product of interest, is about, relative to it's recent testing, (it's previous stock owners of Sirtris Pharmaceuticals was just purchased a few months ago (JUNE 08)) by GSK. By the way, my daughter is a research chemist in the field of pharmaceuticals and patent law. So I guess the interest in this stuff runs in the family! LOL! If a study comes to NIH that I could be eligible for, I'd volunteer, for sure! I think I would wait to buy at around 46 since it seems to be dropping at the moment.
www.nyse.com/about/listed/lcddata.html
www.resveratrol.com/Recent%20News.html
$48.14 (08/12/08)
